glp-1 agonists medications Receptor Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care Market Overview: GLP-1 Agonists and
Description
10.1111/dom.13380
North America led the market by securing a market share of 49.7% in 2024
Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP
Kosiborod M, Lam CSP, Kohsaka S, et al
These molecules mimic the action of two natural hormones involved in metabolism and appetite regulation: GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide)
